Table 2.

Characteristics of the mice used in the study.

		Female		Male		Two-factor ANOVA
		Saline	Cisplatin	Saline	Cisplatin	P sex	P cisplatin	P Interaction
Sample size		7	5	6	6
Age		9	9	9	9
Starting mass	g	20.38 (0.32)	20.77 (0.55)	26.49 (0.69) *	27.70 (0.41) *	<0.001	0.13	0.43
Change in mass	%	−0.55 (1.49)	−13.2 (3.80)*	0.56 (0.92)	−14.33 (2.78)*	0.99	<0.001	0.62
Total kidney mass	mg	0.24 (0.004)	0.21 (0.004)	0.30 (0.01)	0.29 (0.006)	<0.001	0.072	0.38
Kidney/starting body mass	mg/g	11.56 (0.13)	10.20 (0.21) *	11.23 (0.36)	10.43 (0.26)	0.85	0.0006	0.30
Kidney/dissection body mass	mg/g	11.64 (0.12)	12.03 (0.57)	11.13 (0.33)	12.12 (0.55)	0.68	0.069	0.37
Heart mass	mg/dL	0.11 (0.008)	0.092 (0.001)	0.13 (0.007)	0.12 (0.006)	0.0045	0.073	0.76
Heart/starting body mass	mg/g	5.10 (0.32)	4.48 (0.14)	4.79 (0.19)	4.20 (0.19)	0.20	0.016	0.95
Heart/dissection body mass	mg/g	5.20 (0.34)	5.26 (0.14)	4.78 (0.16)	4.96 (0.17)	0.12	0.60	0.77
Plasma creatinine	mg/dL	0.14 (0.01)	0.16 (0.03)	0.13 (0.007)	0.25 (0.06) *	0.19	0.019	0.11
Plasma urea	mg/dL	53.2 (6.6)	76.7 (15.6)	66.9 (4.2)	110.7 (20.5)	0.072	0.014	0.43

Note: Mean (standard error of mean) values are reported. Bold represents statistical significance.

^*indicates significant difference from post hoc Tukey’s analysis.